- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 6.74B sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $171.22M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $182.26M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $11.9M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $65K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $77.83M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $75.29M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $332.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $336.59M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $63.02M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $74.64M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $272.53M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $271.04M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 6.57B sh |
| Capex | Q1 2025 · Mar 31, 2024 | $878K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.51M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $13.73M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $13.18M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$73.38M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$61.67M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $15.88M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$14M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$4.96M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $17.2M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $24.36M |
| Revenue | Q1 2025 · Mar 31, 2024 | $41.56M |